Advances in Inhibitor of P-Glycoprotein

康恺,李运曼
DOI: https://doi.org/10.3969/j.issn.1001-5094.2004.09.005
2004-01-01
Abstract:Multidrug resistance is now recognized as one of the common causes for the failure of cancer chemotherapy. Classic MDR is associated with the overexpression of p-glycoprotein(p-gp), resulting in increased efflux of chemotherapeutic agents from cancer cells and decrement of the therapeutic effect. Therefore, effective inhibiting the activity of p-glycoprotein can be used to reverse the MDR of tumor cells. This article introduces the development of the p-glycoprotein inhibitors, characteristics of 1~3 generation of p-glycoprotein inhibitors, and the clinical trials of the second and third generation of p-glycoprotein inhibitors.
What problem does this paper attempt to address?